Previous studies have shown that the specificity and sensitivity of anti-CCP2 detection for the diagnosis of RA are 96–99% and 47–88% respectively, dependent on the characteristics of the RA population [6], [7]. The gene discussed is AGBL2; the disease is rheumatoid arthritis.